Percutaneous cryoablation of pulmonary metastases from colorectal cancer.
Percutaneous cryoablation of pulmonary metastases from colorectal cancer.
复制标题
DOI:
10.1371/journal.pone.0027086
复制
发表时间:
2011
期刊:
影响因子:
3.7
通讯作者:
Nomori H
中科院分区:
文献类型:
--
作者:
Yamauchi Y;Izumi Y;Kawamura M;Nakatsuka S;Yashiro H;Tsukada N;Inoue M;Asakura K;Nomori H
To evaluate the safety and efficacy of cryoablation for metastatic lung tumors from colorectal cancer. The procedures were performed on 24 patients (36–82 years of age, with a median age of 62; 17 male patients, 7 female patients) for 55 metastatic tumors in the lung, during 30 sessions. The procedural safety, local progression free interval, and overall survival were assessed by follow-up computed tomographic scanning performed every 3–4 months. The major complications were pneumothorax, 19 sessions (63%), pleural effusion, 21 sessions (70%), transient and self-limiting hemoptysis, 13 sessions (43%) and tract seeding, 1 session (3%). The 1- and 3-year local progression free intervals were 90.8% and 59%, respectively. The 3-years local progression free intervals of tumors ≤15 mm in diameter was 79.8% and that of tumors >15 mm was 28.6% (p = 0.001; log-rank test). The 1- and 3-year overall survival rates were 91% and 59.6%, respectively. The results indicated that percutaneous cryoablation is a feasible treatment option. The local progression free interval was satisfactory at least for tumors that were ≤15 mm in diameter.
登录
查看更多内容
DOI:
10.1016/j.jtcvs.2004.10.019
发表时间:
2005-03-01
影响因子:
6
作者:
Fernando, HC;De Hoyos, A;Luketich, JD
通讯作者:
Luketich, JD
影响因子:
--
作者:
Chapman, WC;Debelak, JP;Parker, RE
通讯作者:
Parker, RE
DOI:
10.1016/j.jtcvs.2005.12.051
发表时间:
2006-05-01
影响因子:
6
作者:
Kawamura, M;Izumi, Y;Kobayashi, K
通讯作者:
Kobayashi, K
DOI:
10.1016/j.jvir.2007.06.027
发表时间:
2007-10-01
影响因子:
2.9
作者:
Hiraki, Takao;Gobara, Hideo;Kanazawa, Susumu
通讯作者:
Kanazawa, Susumu
影响因子:
5
作者:
Dupuy, DE;Zagoria, RJ;Safran, H
通讯作者:
Safran, H